| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.74▼ | 1.74▼ | 1.74▼ | 1.87▼ | 2.00▼ |
| MA10 | 1.74▼ | 1.75▼ | 1.78▼ | 1.92▼ | 2.11▼ |
| MA20 | 1.74▼ | 1.79▼ | 1.81▼ | 2.01▼ | 1.30▲ |
| MA50 | 1.77▼ | 1.85▼ | 1.90▼ | 2.11▼ | 1.11▲ |
| MA100 | 1.80▼ | 1.91▼ | 1.97▼ | 1.27▲ | 1.38▲ |
| MA200 | 1.85▼ | 2.00▼ | 2.02▼ | 1.16▲ | 3.52▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.002▼ | -0.006▼ | -0.039▼ | 0.048▲ |
| RSI | 36.710▼ | 27.041▼ | 26.555▼ | 39.034▼ | 56.610▲ |
| STOCH | 25.000 | 9.835▼ | 6.032▼ | 16.376▼ | 43.084 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -98.718▼ | -49.855 |
| CCI | -147.281▼ | -72.110 | -103.781▼ | -176.120▼ | 9.768 |
|
Friday, September 12, 2025 09:15 AM
CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will ...
|
|
Wednesday, August 27, 2025 07:28 AM
(RTTNews) - Vor Biopharma Inc. (VOR), Wednesday announced that its collaborator, RemeGen Co., Ltd, achieved the primary endpoint in Stage A of a Phase 3 clinical study in China evaluating telitacicept ...
|
|
Tuesday, August 26, 2025 05:00 PM
On Wednesday, Vor Bio Inc. (NASDAQ:VOR) announced that its collaborator, RemeGen Co., Ltd., achieved the primary endpoint in Stage A of a Phase 3 clinical study in China evaluating telitacicept in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/09/25 | 1.80 | 1.87 | 1.73 | 1.74 | 3,394,060 |
| 11/09/25 | 1.88 | 1.95 | 1.81 | 1.815 | 8,208,164 |
| 10/09/25 | 1.97 | 1.98 | 1.80 | 1.80 | 6,044,800 |
| 09/09/25 | 2.01 | 2.03 | 1.97 | 2.01 | 4,024,271 |
| 08/09/25 | 1.96 | 2.01 | 1.91 | 1.98 | 4,193,567 |
| 05/09/25 | 1.95 | 2.02 | 1.90 | 1.96 | 3,052,937 |
| 04/09/25 | 1.98 | 2.005 | 1.90 | 1.93 | 4,778,031 |
| 03/09/25 | 2.02 | 2.11 | 1.99 | 2.00 | 3,957,610 |
| 02/09/25 | 1.98 | 2.10 | 1.975 | 2.04 | 3,992,123 |
| 29/08/25 | 2.07 | 2.11 | 1.94 | 1.97 | 3,648,900 |
|
|
||||
|
|
||||
|
|